Back to BlackRock, Inc.

TSHA
6 quarters

Position history for BlackRock, Inc.'s holdings in TAYSHA GENE THERAPIES INC

BlackRock, Inc. holds 18.4M shares of TSHA (TAYSHA GENE THERAPIES INC), worth $82.1M as of 2026-Q1. The position was decreased (-1.5% shares). TSHA represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$82.1M

Current Shares

18.4M

Total Value Change

+$58.7M

Total Shares Change

+4.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
18.4M
-1.5%
$82.1M0.0%$4.53
0
2025-Q4
Increased
18.6M
+13.9%
$102.5M0.0%$5.66
34
2025-Q3
Increased
16.4M
+23.0%
$53.5M0.0%$3.16
36
2025-Q2
Decreased
13.3M
-2.1%
$30.7M0.0%$2.38
0
2025-Q1
Increased
13.6M
+0.4%
$18.9M0.0%$1.93
28
2024-Q4
New
13.5M
-
$23.4M0.0%$1.73
40

Other major holders of TSHA: RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, GOLDMAN SACHS GROUP INC, MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used